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1. Introduction 
Polyglycosylceramides are highly complex, multi- 
branched glycosphingolipids which exhibit ABH and 
I antigenic activity [ 11. They contribute to -15% of 
the total ABH blood group activity of human eryth- 
rocytes [2-S]. About 80% of the activity is provided 
by glycoproteins most of which are of the N-glycosidic 
type. The glycoproteins contain polyglycosylchains 
which are similar in structure to those of polyglycosyl- 
ceramides [6,7]. They were isolated from pronase 
digests of erythrocyte membranes and variously 
designated polyglycosylpeptides [6] or erythroglycan 
[ 71. Polyglycosylpeptides are probably derived from 
band 3 and band 4.5 glycoproteins [4]. We had estab- 
lished that polyglycosylceramides are largely unbran- 
ched in erythrocytes of a rare i phenotype [8]. We now 
show that the impaired branching is also a feature of i 
erythrocyte polyglycosylpeptides. 
2. Materials and methods 
Erythrocytes with i phenotype (200 ml) were 
obtained from a blood group AB individual (M .T.). 
The erythrocytes totally lacked ID component of I 
antigen. The IF component was not depressed. The 
nomenclature is as in [9]. Control I erythrocytes were 
obtained from a type B blood donor. Polyglycosyl- 
ceramides were isolated as in [8] while polyglycosyl- 
peptides as in [7]. The starting material was erythro- 
cyte stroma prepared as in [8]. 
The isolated materials were analysed for carbohy- 
drate constituents as in [8]. Sphingosine was deter- 
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mined as in [lo]. The number of branching points 
was estimated on the basis of 2,4-di_O-methylgalactose 
contents as determined in the methylated and aceto- 
lysed samples [8]. Hemagglutination inhibition assays 
were done as in [8] using blood group 0 erythrocytes 
as indicator cells. Carrier auxilliary lipid was not added. 
Some of the anti-1 and anti-i serums employed in this 
study were used in [8] for measurements of Ii activi- 
ties of polyglycosylceramides isolated from cord, adult 
and i erythrocytes. 
3. Results 
Chemical compositions of polyglycosylceramides 
and of polyglycosylpeptides isolated from i and I 
erythrocytes are shown in table 1. The molar ratios of 
carbohydrates in polyglycosylpeptides were calculated 
on the assumption that there are 3 mannose residues/ 
mol [6,7]. A reduction of yields and molecular com- 
plexity of the two kinds of glycoconjugates from i 
erythrocytes is evident. Results of the examination of 
polyglycosylceramides and polyglycosylpeptides by 
methylation technique is presented in table 2. Owing 
to small amounts of material available we did not 
attempt to quantitate methyl ethers of mannose. The 
most conspicuous differences between glycoconjugates 
from i and I erythrocytes were in 2,4-diO-methyl- 
galactose contents which were very much reduced in 
glycoconjugates from i erythrocytes. 
Table 3 shows I and i activities of the glycoconju- 
gates as determined by hemagglutination inhibition 
technique. Clearly the I activity of polyglycosylpep- 
tides from I erythrocytes is IO-fold lower than that 
of polyglycosylceramides. Polyglycosylpeptides from 
i erythrocytes were inactive or only slightly active 
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Table 1 
Yields and approximate molar ratios of carbohydrates and sphingosine in polyglycosyl- 
ceramides and polyglycosylpeptides from I and i erythrocytes 
Yield mgjlO0 ml of 
erythrocytes 
Fucose 
Galactose 
Glucose 
Mannose 
N-Acetylglucosamine 
N-Acetylgalactosamine 
Sialic acid 
Sphingosine 
Sum of carbohydrate 
residues 
(without sialic acid) 
Polyglycosyl- 
ceramides 
from i cells 
0.33 
1.3 
6.0 
1 .o 
_ 
4.5 
0.4 
n.d. 
0.84 
13.5 
Poiyglycosyl- PolyglycosYl- 
peptides from peptides from 
i cells I cells 
0.75 3.5 
2.0 3.1 
16.5 25.1 
trace 2.0a 
3.0 3.0 
12.9 24.6 
2.3 - 
3.0 2.4 
n.d. - 
36.7 55.8 
a Possibly a contaminant from Sephadex columns; 
n.d.,not determined; - not detectable 
Results for polyglycosylceramides are given assuming that glucose is 1.0 
Table 2 
Approximate molar ratios of the methylated sugar derivatives from polyglycosyl- 
coramides and polyglycosylpeptides of I and i erythrocytes 
Poiyglycosyl- 
ceramides 
from i cells 
Polygiycosyl- 
peptides from 
i cells 
Polyglycosyl- 
peptides 
from I cells 
2,3,4J%Me ,FucOH 
2,3,4,6@Me,GalOH 
2,4,6-Q-Me,GalOH 
2,3,4C)-Me,GalOH 
3,4,6a-Me,GalOH 
2,4~~e~GalOH 
4,6-O-Me,GalOH 
2,3,6U-Me,GlcOH 
3,6_OMe,GlcNAcMeOH 
3,4,6-&Me,GalNAcMeOH 
1.2 2.0 3.0 
0.4 0.7 4.5 
3.4 12.6 10.5 
_ - 1.2 
0.6 - - 
0.8 0.7 9.1 
1.0 2.5 1.5 
1.0 - - 
4.5 12.9 24.6 
0.4 2.3 
Calculations were made on the assumption that 3,6X%Me,GlcNAcMeOH is equivalent o 
the totalNacetylglucosamine as determined by alditol acetate technique. Derivatives of 
mannose are not shown 
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Table 3 
October 1980 
I and i activities of poly~ycosyiceramides and polyglycosylpeptides 
Substance and source Serum 
ant#Baj a~ti-IDS~um anti-fFZaw anti-i St 
Polyglycosyl~emm~es 
from pooled I (B) erythrocytes 72 36 I44 -2300 
Polyglycosylpeptides 
from I (B) erythrocytes 700 700 700 >2800 
Poly8ly~sylpeptides 
from i erythrocytes .830 .830 -830 103.7 
- incomplete inhibition 
Results are expressed as minimum amount of substances in pg which inhibit hemagglutination 
with anti-1 serums but in~bited anti-i serum St. The 
same anti-i serum was shown in [8] to react with poly- 
glycosylceramides isolated from i erythrocytes of a 
different donor Dr. The antiserum isonly partially 
inhibited by poly~ycosylceramides from pooled I 
e~thro~ytes. Foly~yco~lceramides from i erythro- 
cytes of the donor M .T. could not be assayed for 
serological activity due to a limited amount of the 
material. 
4. Discussion 
Yields, molar ratios of sugars and methylation data 
for polyglycosylceramides obtained from i erythro- 
cytes of the donor M.T. are practically identical to 
those reported for i erythrocytes of the donor Dr [8]. 
The values are signi~cantly different from those for 
‘normal’ poly~y~osylcera~des from I erythrocytes. 
The latter have an av. 30 sugar esidues/mol and 
-4-S branching points [ I$]. The yield amounts to 
12 + 0.27 mgJlO0 ml erythrocytes. Data for poly 
~y~osylpeptides from i.e~throcytes are reported for 
the first time. In [8] we had shown only that glyco- 
proteins from i erythrocytes that are labelled with A!- 
{ r4C] acetylgalactosamine with the aid of A enzyme 
(EC 2.4.1.40) have reduced molecular weights as 
judged by SDS gel electrophoresis [8]. These data 
show that poly~ycosylpeptides from i e~throcytes 
have practically straight saccharide chains. In contrast 
there are 9 branching points in poly~y~osylpeptides 
isolated from control I erythrocytes. The latter value 
compares favorably with the number of 8.5 branching 
points reported for e~~ro~ycon 171. These results 
are in keeping with our hypothesis that i phenotype 
results from a deficiency of the biosynthetic process 
which leads to the formation of GlcNAc 1 -+ 6 Gal 
sequence [ 11. The sequence should initiate most of 
side chains in polygly~osylceramides [ 111. It would 
be ~terest~g to learn whether the deficient branching 
of glycoconjugates in individu~s of i phenotype is 
restricted to erythrocytes or is manifested also in 
other types of cells. 
We report for the fast time direct measurements 
of Ii activities of poly~ycosylpeptides. The low I 
activity of poly~ycosylpeptides from I erythrocytes 
relative to that of poly~ycosylceramides might be 
attributed to the fact that the latter form micells in 
aqueous olution [ 1,12,13] and thus exhibit enhanced 
activity in hema~u~ation inhibition tests [ 141. 
Another factor which could contribute to the higher 
activity of poly~ycosylceramides is that they are 
obtained from pooled blood of at least 20 donors. 
The absence of I activity and the presence of i 
activity in unbranched poly~ycosylpeptides from i 
e~~rocytes lend further support o the concept hat 
anti-1 ~tibodies recognize the repeating structure galac- 
tosyl /I( 1 + 4).2deoxy-2~~etamido~ucosyl /I( 1 + 3). 
Anti-i antibodies hould on the other hand react with 
the same structure but branched at carbon atom 6 of 
ealactose with ~~cetylglucosamine [8,15,16]. 
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